NM_004380.3:c.5933A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004380.3(CREBBP):​c.5933A>G​(p.Asn1978Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00542 in 1,581,462 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N1978K) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0043 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0055 ( 24 hom. )

Consequence

CREBBP
NM_004380.3 missense

Scores

3
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9O:1

Conservation

PhyloP100: 3.38

Publications

24 publications found
Variant links:
Genes affected
CREBBP (HGNC:2348): (CREB binding protein) This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
CREBBP Gene-Disease associations (from GenCC):
  • Rubinstein-Taybi syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • Rubinstein-Taybi syndrome due to CREBBP mutations
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • Menke-Hennekam syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0054739416).
BP6
Variant 16-3729114-T-C is Benign according to our data. Variant chr16-3729114-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 95057.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00427 (647/151668) while in subpopulation NFE AF = 0.00627 (425/67818). AF 95% confidence interval is 0.00577. There are 3 homozygotes in GnomAd4. There are 299 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 647 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004380.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CREBBP
NM_004380.3
MANE Select
c.5933A>Gp.Asn1978Ser
missense
Exon 31 of 31NP_004371.2
CREBBP
NM_001079846.1
c.5819A>Gp.Asn1940Ser
missense
Exon 30 of 30NP_001073315.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CREBBP
ENST00000262367.10
TSL:1 MANE Select
c.5933A>Gp.Asn1978Ser
missense
Exon 31 of 31ENSP00000262367.5
CREBBP
ENST00000382070.7
TSL:1
c.5819A>Gp.Asn1940Ser
missense
Exon 30 of 30ENSP00000371502.3

Frequencies

GnomAD3 genomes
AF:
0.00427
AC:
647
AN:
151544
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00289
Gnomad ASJ
AF:
0.0130
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000417
Gnomad FIN
AF:
0.00703
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00627
Gnomad OTH
AF:
0.00288
GnomAD2 exomes
AF:
0.00505
AC:
1024
AN:
202582
AF XY:
0.00492
show subpopulations
Gnomad AFR exome
AF:
0.000873
Gnomad AMR exome
AF:
0.00364
Gnomad ASJ exome
AF:
0.0151
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00914
Gnomad NFE exome
AF:
0.00689
Gnomad OTH exome
AF:
0.00662
GnomAD4 exome
AF:
0.00554
AC:
7925
AN:
1429794
Hom.:
24
Cov.:
34
AF XY:
0.00545
AC XY:
3870
AN XY:
710252
show subpopulations
African (AFR)
AF:
0.000729
AC:
24
AN:
32936
American (AMR)
AF:
0.00319
AC:
134
AN:
42014
Ashkenazi Jewish (ASJ)
AF:
0.0152
AC:
391
AN:
25752
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38286
South Asian (SAS)
AF:
0.000192
AC:
16
AN:
83426
European-Finnish (FIN)
AF:
0.00839
AC:
337
AN:
40190
Middle Eastern (MID)
AF:
0.00244
AC:
14
AN:
5732
European-Non Finnish (NFE)
AF:
0.00604
AC:
6653
AN:
1102050
Other (OTH)
AF:
0.00599
AC:
356
AN:
59408
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
510
1020
1530
2040
2550
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
244
488
732
976
1220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00427
AC:
647
AN:
151668
Hom.:
3
Cov.:
32
AF XY:
0.00403
AC XY:
299
AN XY:
74136
show subpopulations
African (AFR)
AF:
0.00121
AC:
50
AN:
41398
American (AMR)
AF:
0.00288
AC:
44
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.0130
AC:
45
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5096
South Asian (SAS)
AF:
0.000418
AC:
2
AN:
4788
European-Finnish (FIN)
AF:
0.00703
AC:
74
AN:
10530
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00627
AC:
425
AN:
67818
Other (OTH)
AF:
0.00285
AC:
6
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
34
67
101
134
168
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00539
Hom.:
2
Bravo
AF:
0.00420
ESP6500AA
AF:
0.00114
AC:
5
ESP6500EA
AF:
0.00594
AC:
51
ExAC
AF:
0.00469
AC:
564
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (5)
-
-
3
not provided (3)
-
-
1
Inborn genetic diseases (1)
-
-
1
Rubinstein-Taybi syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
21
DANN
Benign
0.90
DEOGEN2
Benign
0.40
T
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.0095
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Uncertain
0.94
D
MetaRNN
Benign
0.0055
T
MetaSVM
Benign
-0.60
T
MutationAssessor
Benign
1.7
L
PhyloP100
3.4
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.26
Sift
Benign
0.34
T
Sift4G
Benign
0.79
T
Polyphen
0.12
B
Vest4
0.14
MVP
0.77
MPC
0.30
ClinPred
0.0060
T
GERP RS
5.0
Varity_R
0.063
gMVP
0.17
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112906840; hg19: chr16-3779115; COSMIC: COSV52116951; COSMIC: COSV52116951; API